Neusignal Therapeutics, Inc.

About Neusignal Therapeutics

Tokyo-based biotech startup founded 2022 developing NTX-083 for Alzheimer’s.

Official website: neusignal-tx.com

About Neusignal Therapeutics on our platform

To provide comprehensive coverage, we aggregate data and news under the name Neusignal Therapeutics, encompassing the following company names, divisions, and related entities:

Neusignal Therapeutics Inc..

This list encompasses current and former names, alternate names, and key divisions associated with Neusignal Therapeutics, ensuring you can easily find all relevant information under a single, unified profile.